Sartorius AG Xetra

SRT

DE0007165607

Advanced Medical Equipment & Technology

Real-time Estimate Tradegate Other stock markets 11:17:47 2024-04-16 am EDT			5-day change	1st Jan Change
258 ^EUR	-1.53%		-5.14%	-2.45%

Apr. 09	Correction: Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	MT
Apr. 09	Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	MT

SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating

January 31, 2022 at 05:03 am EST

In a research note, JP Morgan analyst Richard Vosser has maintained his recommendation on the stock with a Buy rating. No major update to the target price set at EUR 685 compared to EUR 665.

Latest news about Sartorius AG

Correction: Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	Apr. 09	MT
Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience	Apr. 09	MT
Sartorius falls - outlook from Repligen disappointed	Feb. 21	DP
Sartorius Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
Sartorius gains despite halving dividend	Feb. 09	DP
Sartorius Board Proposes Lower FY23 Dividend	Feb. 09	MT
Sartorius to halve dividend	Feb. 09	DP
Debt reduction: Sartorius sells shares - Stedim with capital increase	Feb. 07	DP
Germany's Sartorius Raises EUR200 Million Via Share Issue	Feb. 07	MT
Sartorius Stedim Biotech Raises EUR1.2 Billion in Fresh Capital from Share Sale	Feb. 07	MT
Pharmaceutical stocks lag behind - Bayer at its lowest level since the end of 2005	Jan. 30	DP
SARTORIUS : FY23: Updated mid-term outlook offers much valued ‘certainty’	Jan. 29
Upbeat Sartorius Outlook Leads German Shares to Close Higher	Jan. 26	MT
Sartorius at the top of the Dax after figures and outlook	Jan. 26	DP
Sartorius Posts Decline in FY23 Preliminary Net Profit; Sales Revenue Down	Jan. 26	MT
Sartorius thwarted by 21-day line - despite HSBC recommendation	Jan. 10	DP
Sartorius weak - Deutsche Bank: Highly valued	Jan. 04	DP
Sartorius at the top of the Dax - JPMorgan sees share price driver in figures	Jan. 02	DP
SARTORIUS : Target cut by -3.4%	Dec. 22
German Shares Fall as Downward Q3 US GDP Revision Weighs	Dec. 21	MT
Expensive energy, empty state coffers - chemical industry with little confidence	Dec. 15	DP
Sartorius recovery continues - test of the 100-day line	Dec. 11	DP
Sartorius hits further low since May 2020	23-10-20	DP
Sartorius profits slump - Borse celebrates first signs of recovery	23-10-19	DP
Sartorius Aktiengesellschaft Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-19	CI

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.

Sector

Advanced Medical Equipment & Technology

Related indices

STOXX EUROPE 600 (EUR) , DAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

SARTORIUS : FY23: Updated mid-term outlook offers much valued ‘certainty’

January 29, 2024 at 09:04 am EST

More Strategies

Ratings for Sartorius AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

342.4 EUR

Average target price

352.3 EUR

Spread / Average Target

+2.90%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
QUIDELORTHO CORPORATION	-45.65%	2.77B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+7.25%	1.7B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-7.99%	1.53B
BIOTAGE AB	+27.30%	1.27B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-13.75%	991M
CONTEC MEDICAL SYSTEMS CO.,LTD	-23.36%	878M
REVENIO GROUP OYJ	-4.79%	742M
VAREX IMAGING CORPORATION	-15.46%	707M
CELLAVISION AB	+3.77%	476M

Medical Diagnostic & Testing Equipment

Sartorius AG Xetra

Equities

SRT

DE0007165607

Advanced Medical Equipment & Technology

SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating

Latest news about Sartorius AG

Chart Sartorius AG

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Sartorius AG

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment